Yüklüyor......

Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus

AIM: To investigate the real-world efficacy and safety of sofosbuvir/ribavirin (SOF/RBV) therapy for Japanese patients with genotype 2 hepatitis C virus (GT2-HCV). METHODS: A total of 182 patients with GT2-HCV infection who received SOF/RBV therapy for 12 wk at our hospital were enrolled. The patien...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:World J Gastroenterol
Asıl Yazarlar: Yada, Masayoshi, Miyazaki, Masayuki, Tanaka, Kosuke, Masumoto, Akihide, Motomura, Kenta
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Inc 2018
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889827/
https://ncbi.nlm.nih.gov/pubmed/29632428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v24.i13.1478
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!